TCR2 Therapeutics Inc (TCRR)
NASDAQ:TCRR
Holding TCRR?
Track your performance easily

TCR2 Therapeutics (TCRR) Stock Investors

404 Followers
Based on 703,211 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold TCRR
On average, investors allocate 2.98% of their portfolios to TCRR
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 703,211 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding TCRR

1.1%
Last 7
Days
9.8%
Last 30
Days
Percentages indicate the change in the number of portfolios holding TCRR, out of 703,211 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

TCRR Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.04%
$1.96
Based on the activity of 12,882 investors who made their portfolios public
The table shows changes in TCRR in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

TCRR Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Moderna
5.44%
+0.18%
+1.43%
46.89B
Healthcare
Syros Pharmaceuticals
3.80%
-1.11%
-6.19%
71.26M
Healthcare
Twilio
3.09%
+1.51%
+1.62%
11.28B
Technology
Merck & Company
4.66%
-0.11%
-0.47%
276.05B
Healthcare
Applied Materials
4.57%
-0.02%
+0.43%
116.18B
Technology
Blink Charging Co
4.05%
+0.55%
+2.53%
387.47M
Utilities
DraftKings
6.53%
-0.05%
+2.92%
26.17B
Technology
Li Auto
5.51%
+0.78%
+4.04%
35.49B
Consumer Cyclical
Micron
5.56%
-0.42%
+2.47%
71.72B
Technology
Marvell
4.85%
+0.23%
+1.14%
54.27B
Technology
Based on the activity of 703,211 active portfolios
Open your Smart Portfolio

TCRR Investor Analysis

TCRR investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
50.0%
of TCRR holders
are under 35
Average Segment Performance
Average P/E Ratio20.30
Beta8.53
Dividend Yield13.56%
TCRR investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
50.0%
of TCRR holders
are between 35–55
Average Segment Performance
Average P/E Ratio18.05
Beta12.75
Dividend Yield23.61%
TCRR investors over 55

Over 55

3.7%
Last 30 days
Holdings Change
0.0%
of TCRR holders
are over 55
Average Segment Performance
Average P/E Ratio16.59
Beta5.76
Dividend Yield11.70%
Overview of age group and performance of TCRR stock investors
See who invests in TCRR according to age group and performance.

FAQ

How many retail Investors hold TCRR?
<0.1% of TipRanks' retail investors hold TCRR in their portfolios.
    What is TCRR Investor Sentiment?
    TCRR’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of TCRR in the last 7 days?
      ▼ 1.1% of TipRanks' retail investors changed their holding of TCRR in the last 7 days.
        What percentage of retail investors changed their holding of TCRR in the last 30 days?
        ▼ 9.8% of TipRanks' retail investors changed their holding of TCRR in the last 30 days.
          What is the average age of retail investors who hold TCRR?
          The average age of TCRR Holders is between 35–55.
            What other stocks have TCRR investors also bought?
            TCRR Investors also bought MRNA, SYRS, TWLO, MRK, AMAT, BLNK, DKNG, LI, MU, MRVL.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              ATECAlphatec Holdings
              ABCAmerisourceBergen
              AZNAstraZeneca
              BMRNBioMarin Pharmaceutical
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis